Buy, hold, sell: CSL, Steadfast, and Wesfarmers shares

Ord Minnett has given its verdict on these shares.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The team at Ord Minnett has been busy running the rule over a number of big-name ASX 200 shares recently.

Does the broker rate them as buys, holds, or sells? Let's see what it is saying:

Businessman working and using Digital Tablet new business project finance investment at coffee cafe.

Image source: Getty Images

CSL Ltd (ASX: CSL)

Ord Minnett continues to rate CSL shares as a hold with a $117.00 price target. This is largely in line with its current share price of $116.32.

The broker believes the market is underestimating the challenges that its CSL Vifor business is facing and is expecting earnings below consensus estimates. It explains:

Ord Minnett has reviewed its CSL (CSL) model further with a focus on its Vifor nephrology business that is facing challenges which, in our view, are being underestimated by the broader market. Our estimates for Vifor revenue and operating profit in FY27 are below consensus estimates by 15% and 32%, respectively, while our forecasts for operating profit across the FY27–FY29 horizon are more than 10% below market expectations.

Our target price on CSL is unchanged at $117.00 post this latest review. Despite the apparent significant upside [previously] on offer, Ord Minnett maintains its Hold recommendation on the stock given the significant uncertainty around the earnings outlook and broader issues as management attempts to reset the business.

Steadfast Group Ltd (ASX: SDF)

Takeover target Steadfast has been given a hold rating and $6.00 price target by Ord Minnett. This compares to its current share price of $5.15.

It notes that the insurance broker recently received a takeover bid of $6.00 per share from a consortium led by American wholesale insurance distributor Amwins. Ord Minnett believes that this may be the best the shareholders get. It said:

Absent the current bid, the chances of realising a value for the company of $6.00 a share any time soon would appear remote, even if that price is towards the bottom end of its historical trading range. We make no changes to our EPS estimates but raise our target price to $6.00 from $5.55 and lower our recommendation to Hold from Buy.

Wesfarmers Ltd (ASX: WES)

Finally, Ord Minnett has also put a hold rating on Wesfarmers shares with a price target of $75.00. This is below its current share price of $85.76.

It was pleased with its strategy day presentation, but believes its shares are fully valued based on a sum of the parts valuation. It commented:

Wesfarmers (WES) delivered a well-received presentation at its strategy day where the retail and industrial conglomerate laid out how plans to exploit AI and leverage its data to accelerate its long-term sales and earnings growth at its key Bunnings, Kmart, and Officeworks businesses.

Post the strategy day, we have made minor changes to our EPS estimates to incorporate Officeworks transformation costs, a lower contracted price and reduced spodumene concentrate price for the Covalent lithium arm, and currency impacts. Overall, this drives reductions in our EPS forecasts of 0.2%, 1.2% and 0.8% over FY26, FY27 and FY28, respectively. We raise our sum-of-the-parts (SOTP)-derived target price on Wesfarmers to $75.00 from $70.00 to factor in higher earnings multiples but reiterate our Hold recommendation on valuation grounds.

Motley Fool contributor James Mickleboro has positions in CSL. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL, Steadfast Group, and Wesfarmers. The Motley Fool Australia has positions in and has recommended Steadfast Group. The Motley Fool Australia has recommended CSL and Wesfarmers. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

colleagues on a lunch break looking at iPhone
Broker Notes

Top brokers name 3 ASX shares to buy now

Here's what brokers are recommending as buys this week.

Read more »

Logistic workers sitting amid pallets and stock in a warehouse.
Broker Notes

Brambles shares: Buy, hold or sell?

A leading analyst provides his forecast for Brambles' rebounding share price.

Read more »

An older woman tries to listen by cupping her ear.
Broker Notes

Down 62%, should I buy Cochlear shares now?

Two leading analysts offer their outlooks for Cochlear’s beaten-down share price.

Read more »

Red sell button on an Apple keyboard.
Broker Notes

Sell alert! Why this expert is calling time on Westpac shares

A top analyst forecasts growing headwinds for Westpac shares. But why?

Read more »

Arrows pointing upwards with a man pointing his finger at one.
Broker Notes

Which ASX mining stock could rocket 100%+ after 'breakthrough'?

This mining stock could be undervalued according to Bell Potter.

Read more »

A woman in a red dress holding up a red graph.
Broker Notes

3 ASX shares with 39% to 141% growth ahead of them: Experts

If you're looking for capital gains, try these shares on for size.

Read more »

A young man talks tech on his phone while looking at a laptop with a financial graph superimposed across the image.
Broker Notes

Buy, hold, sell: How does Morgans rate these ASX shares?

One of these shares could deliver a 50% return according to the broker.

Read more »

Three generation of women cuddling and smiling together.
Broker Notes

3 reasons to buy the dip on Life360 shares today

A leading analyst believes Life360 shares are well-placed to outperform. But why?

Read more »